Investors
Quote of the day
19/03/2026 12h45
0,1996 €
The latest information
ARCHOS 2025
Reduction of share capital by reducing the par value of shares – Transfer of registered office
151% pro forma sales growth in 2023, after integration of 12 months of Elexo, 37% growth including November and December 2023, post-acquisition
Archos announces the establishment of a management trust following the acquisition of blocks of MDV shares, in connection with the proposed delisting of MDV shares from the Euronext Access+ Paris market.
Shares and voting rights at 11/30/2023
Acquisition of blocks of MDV shares in connection with the proposed delisting of MDV shares from the Euronext Access+ Paris market in order to facilitate MDV’s financing with private equity funds operating in the healthcare sector, as well as the conclusion of amendment no. 5 to the financing agreement with YA II PN, Ltd and the drawing down of a tranche of OCAs.
First listing of Archos consolidated shares (ALJXR / FR001400KO61)
Reduction in capital due to losses by reducing the par value of shares, effective November 13, 2023
